Therapy of rabies encephalitis.
Alan C
AC
Jackson
D000293:Adolescent; D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D057134:Antibodies, Neutralizing / Q000096:biosynthesis / Q000276:immunology; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000276:immunology; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002685:Chiroptera / Q000821:virology; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D054810:Deep Sedation / Q000009:adverse effects; D004569:Electroencephalography / Q000187:drug effects; D018792:Encephalitis, Viral / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D008874:Midazolam / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010634:Phenobarbital / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011818:Rabies / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D011820:Rabies virus / Q000276:immunology; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*
D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D000998:Antiviral Agents; D018691:Excitatory Amino Acid Antagonists; D012254:Ribavirin; D007649:Ketamine; D000547:Amantadine; D008874:Midazolam; D010634:Phenobarbital